Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Lowe`s Companies Inc (LOW) vs Tilray Brands Inc (TLRY) Price & Performance

Lowe`s Companies IncTrade
Tilray Brands IncTrade

Price performance (Past 24H)

Key statistics

Lowe`s Companies Inc vs Tilray Brands Inc — how do they compare? Lowe`s Companies Inc trades at $186.7 (market cap $105.96B), while Tilray Brands Inc trades at $3.54 (market cap $530.54M). The key difference: Lowe`s Companies Inc is far larger — about 199.7× Tilray Brands Inc's market cap, and Lowe`s Companies Inc pays a 2.65% dividend while Tilray Brands Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Lowe`s Companies Inc for 98 Days and Tilray Brands Inc for 31 Days on average.

LOWTLRY
Market Cap
$105.96B$530.54M
Volume
4,039,5479,099,075
Sector
Consumer CyclicalHealth
52-Week High
$287.39$21.00
52-Week Low
$179.50$3.57
Typical Hold Time
98 Days31 Days
Enterprise Value
$144.81B$684.46M
Dividend Yield
2.65%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Lowe`s Companies Inc

Lowe's (LOW) trades at $186.00, up 2.46% with recent earnings beats but faces bearish technical signals. The stock shows solid fundamentals with a P/E of 15.96 and net margin of 7.35%, though revenue has declined from $96.2B in 2022 to $83.7B in 2025. Recent news highlights drone delivery innovation with DoorDash and Alphabet, while the home improvement sector faces macroeconomic headwinds.

Wall Street maintains a bullish consensus with a $244.09 price target (31 Buy, 19 Hold, 1 Sell), representing 31% upside potential. Key risks include housing market stagnation and competitive pressure from Home Depot. The negative shareholder equity position requires monitoring, but consistent dividend payments and operational cash flow strength provide stability.

Tilray Brands Inc

Tilray Brands (TLRY) trades at $3.50, down 5.79% on the day and near its 52-week low. The stock shows bearish technical signals with negative moving averages and recent earnings misses across four consecutive quarters. Despite revenue growth to $821 million in 2025, the company reported a substantial net loss of $2.19 billion, driven by impairment charges and high operating costs. Analyst sentiment remains cautious with 65% hold ratings, though the consensus price target of $65.01 suggests significant potential upside from current levels.

The outlook remains challenging with persistent profitability issues and negative cash flow from operations. Investment opportunity exists if Tilray can achieve projected 2026 revenue growth to $915 million and reduce losses. Key risks include ongoing operational inefficiencies, competitive pressures in the cannabis market, and regulatory uncertainty. The stock's current valuation at 0.44 P/S and 0.33 P/B may attract value investors betting on a turnaround.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

LOW
2% Buy98% Sell
Avg holding period · 98 Days
TLRY
54% Buy46% Sell
Avg holding period · 31 Days

Top news

Latest headlines on both assets

About Lowe`s Companies Inc

Lowe's is the second-largest home improvement retailer in the world, operating 1,969 stores and servicing around 230 dealer-owned stores throughout the United States and Canada. The firm's stores offer products and services for home decorating, maintenance, repair, and remodeling, with maintenance and repair accounting for two thirds of products sold. Lowe's targets retail do-it-yourself (around 75% of sales) and do-it-for-me customers as well as commercial and professional business clients (around 25% of sales). We estimate Lowe's captures a low-double-digit share of the domestic home improvement market, based on U.S. Census data and management's estimates for market size.

Read more on LOW →

About Tilray Brands Inc

Tilray is a Canadian company that grows and sells medical and recreational cannabis. In 2021, Aphria acquired Tilray in a reverse merger and adopted the Tilray name. Most of its sales come from Canada and international medical cannabis exports, while its U.S. business focuses on CBD products and alcohol.

Read more on TLRY →